Riverdale, MD · Health Care · Form D filed Sep 11, 2026
Savannah Therapeutics, Inc raised $3.9M
Savannah Therapeutics, Inc is a health care company based in Riverdale, Maryland. In a Form D filed with the SEC on September 11, 2026, it reported raising $3,855,000 from 28 investors as part of an offering of up to $6,000,000. The first sale in the offering took place on April 17, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Still raising. $2.1M of the $6M offering was still unsold at filing.
$3.9M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 11, 2026 | $3.9M | $6M | 28 |
Lead score
39 out of 100
first raise ever still raising budget to spend young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $3,855,000
- Offering size
- $6,000,000
- Investors so far
- 28
- Minimum investment
- $25,000
- First sale
- April 17, 2026
- Securities offered
- Debt
- Exemption claimed
- Rule 506(b)
- Industry
- Health Care
- Headquarters
- Riverdale, Maryland
- Incorporated
- Delaware, 2026
- Entity type
- Corporation
- Revenue range
- No Revenues
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $3,855,000 | $6,000,000 | 28 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 7, 2026 · Health Care funding in Maryland · September 2026 funding report
Similar raises
Kaigene, Inc.
Rockville, MD · filed Oct 142nd Form D since 2022Still raising
ColoWatch, Inc.
Gaithersburg, MD · filed Oct 8
Virtual colonoscopy screening with no sedation, standardized protocols, secure cloud delivery, advanced 3D visualization, and expert radiologist interpretation.
First Form DStill raising
Templar Nova, Inc.
Rockville, MD · filed Oct 7First Form D
Monocacy Therapeutics Inc.
Monrovia, MD · filed Oct 75th Form D since 2026
Seraxis Holdings, Inc.
Germantown, MD · filed Sep 24
Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.
2nd Form D since 2021
Aromha, Inc.
Potomac, MD · filed Sep 243rd Form D since 2025
Uvantis Therapeutics, Inc.
Columbia, MD · filed Sep 23First Form DStill raising
Functional Longevity Labs, Inc.
Easton, MD · filed Sep 21First Form DStill raising